Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement

BACKGROUND: Chronic Graft-versus-Host Disease (cGVHD) can impact quality of life, especially in patients with oral involvement. Half of the patients with cGVHD do not respond to first-line therapy with corticosteroids and calcineurin inhibitors. Ruxolitinib is effective in steroid-refractory (SR)-cG...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaurinovic, Martina, Delli, Konstantina, Jonk, Ana-Mae E., Biswana, Anouschka, Hazenberg, Carin L. E., Choi, Goda, de Groot, Marco R., Morsink, Linde M., Vissink, Arjan, Bellido, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072523/
https://www.ncbi.nlm.nih.gov/pubmed/35169886
http://dx.doi.org/10.1007/s00784-022-04393-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072523/
https://www.ncbi.nlm.nih.gov/pubmed/35169886
http://dx.doi.org/10.1007/s00784-022-04393-1

Ejemplares similares